Hi,
Please find below the budget expectations/ wish list of Mr. P. N. Venugopalan, President of Actis Biologics Pvt. Ltd.
Actis Biologics Pvt Ltd: A high end biotechnology company in the country; it is the only company in the country and among few in the world, doing active research (through Gene Therapy Program) to develop biotech drugs for breast cancer. The Malaysian Government with its appetite for new scientific developments has provided a collaborative venture for the company to build up a biotech park called Biocity in
Please find the attached profile of Mr. P.N. Venugopalan with his one photograph.
I have also attached the profile of Actis Biologics Pvt. Ltd. for your perusal.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
BUDGET EXPECTAIONS OF MR. P.N. VENUGOPALAN, PRESIDENT OF ACTIS BIOLOGICS PVT. LTD
To encourage intellectual property in the country for biotech industries, government should initiate the following:
Totally remove duties on research equipments used for biotech research.
government should also remove personal income-tax burdens of research workers and associates, to help reduce wages / salary expenses of research based companies - particulary those which are not revenue generating. Specific incentives should be given to biotech research companies which are exclusively supported by the investors and institutions - including government.
This proposal, if ever implemented, will increase biotech patent assets of the country.
REGARDS,
P. N. VENUGOPALAN
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Best Regards,
Adfactors PR Pvt Ltd
Rajmahal, 3rd Floor,
Mumbai 400020.
Tel: +91 22 2204 9803-04
Fax: +91 22 2204 9814
Email: shaily.malviya@adfactorspr.com
P Let
The information in this email is confidential and is intended solely for the addressee(s). Access to this email by anyone else is unauthorized. If you are not an intended recipient, you must not read, use or disseminate the information contained in this email.
__________ Information from ESET NOD32 Antivirus, version of virus signature database 4187 (20090625) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
__________ Information from ESET NOD32 Antivirus, version of virus signature database 4196 (20090629) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
__________ Information from ESET NOD32 Antivirus, version of virus signature database 4196 (20090629) __________
The message was checked by ESET NOD32 Antivirus.
http://www.eset.com
No comments:
Post a Comment